Literature DB >> 21828376

Role of medical history and medication use in the aetiology of upper aerodigestive tract cancers in Europe: the ARCAGE study.

T V Macfarlane1, G J Macfarlane, N S Thakker, S Benhamou, C Bouchardy, W Ahrens, H Pohlabeln, P Lagiou, A Lagiou, X Castellsague, A Agudo, A Slamova, J Plzak, F Merletti, L Richiardi, R Talamini, L Barzan, K Kjaerheim, C Canova, L Simonato, D I Conway, P A McKinney, P Thomson, P Sloan, A Znaor, C M Healy, B E McCartan, M Marron, P Brennan.   

Abstract

BACKGROUND: The study aimed to investigate the role of medical history (skin warts, Candida albicans, herpetic lesions, heartburn, regurgitation) and medication use (for heartburn; for regurgitation; aspirin) in the aetiology of upper aerodigestive tract (UADT) cancer.
METHODS: A multicentre (10 European countries) case-control study [Alcohol-Related CAncers and GEnetic susceptibility (ARCAGE) project].
RESULTS: There were 1779 cases of UADT cancer and 1993 controls. History of warts or C. albicans infection was associated with a reduced risk [odds ratio (OR) 0.80, 95% confidence interval (CI) 0.68-0.94 and OR 0.73, 95% CI 0.60-0.89, respectively] but there was no association with herpetic lesions, heartburn, regurgitation or medication for related symptoms. Regurgitation was associated with an increased risk for cancer of the oesophagus (OR 1.47, 95% CI 0.98-2.21). Regular aspirin use was not associated with risk of UADT cancer overall but was associated with a reduced risk for cancer of oesophagus (OR 0.51, 95% CI 0.28-0.96), hypopharynx (OR 0.53, 95% CI 0.28-1.02) and larynx (OR 0.74, 95% CI 0.54-1.01).
CONCLUSIONS: A history of some infections appears to be a marker for decreased risk of UADT cancer. The role of medical history and medication use varied by UADT subsites with aspirin use associated with a decreased risk of oesophageal cancer and suggestive of a decreased risk of hypopharyngeal and laryngeal cancers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21828376     DOI: 10.1093/annonc/mdr335

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  9 in total

Review 1.  NSAID therapy for PIK3CA-Altered colorectal, breast, and head and neck cancer.

Authors:  Yi Cai; Andrew Yousef; Jennifer R Grandis; Daniel E Johnson
Journal:  Adv Biol Regul       Date:  2019-09-15

2.  Non-steroidal anti-inflammatory drugs use is associated with reduced risk of inflammation-associated cancers: NIH-AARP study.

Authors:  Fatma M Shebl; Ann W Hsing; Yikyung Park; Albert R Hollenbeck; Lisa W Chu; Tamra E Meyer; Jill Koshiol
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

3.  Nonsteroidal anti-inflammatory drugs using and risk of head and neck cancer: a dose-response meta analysis of prospective cohort studies.

Authors:  Jun Shi; Weidong Leng; Lunhua Zhao; Chenli Xu; Jue Wang; Xiaoli Chen; Yu Wang; Xingchun Peng
Journal:  Oncotarget       Date:  2017-10-05

4.  Association of nonsteroidal anti-inflammatory drugs and aspirin use and the risk of head and neck cancers: a meta-analysis of observational studies.

Authors:  Lanhua Tang; Huabin Hu; Huai Liu; Chengzhu Jian; Hui Wang; Jin Huang
Journal:  Oncotarget       Date:  2016-10-04

5.  Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies.

Authors:  Yan Qiao; Tingting Yang; Yong Gan; Wenzhen Li; Chao Wang; Yanhong Gong; Zuxun Lu
Journal:  BMC Cancer       Date:  2018-03-13       Impact factor: 4.430

6.  Aspirin associated with risk reduction of secondary primary cancer for patients with head and neck cancer: A population-based analysis.

Authors:  Yu-Shan Lin; Chih-Ching Yeh; Shiang-Fu Huang; Yi-Sheng Chou; Li-Tang Kuo; Fung-Chang Sung; Chih-Hsin Muo; Chien-Tien Su; Fu-Hsiung Su
Journal:  PLoS One       Date:  2018-08-22       Impact factor: 3.240

7.  NSAIDs Overcome PIK3CA Mutation-Mediated Resistance to EGFR Inhibition in Head and Neck Cancer Preclinical Models.

Authors:  Hua Li; Noah D Peyser; Yan Zeng; Patrick K Ha; Daniel E Johnson; Jennifer R Grandis
Journal:  Cancers (Basel)       Date:  2022-01-20       Impact factor: 6.639

8.  Aspirin and non-steroidal anti-inflammatory drug use and the risk of upper aerodigestive tract cancer.

Authors:  T V Macfarlane; K Lefevre; M C Watson
Journal:  Br J Cancer       Date:  2014-09-11       Impact factor: 7.640

9.  Family history of cancer, personal history of medical conditions and risk of oral cavity cancer in France: the ICARE study.

Authors:  Loredana Radoï; Sophie Paget-Bailly; Florence Guida; Diane Cyr; Gwenn Menvielle; Annie Schmaus; Matthieu Carton; Sylvie Cénée; Marie Sanchez; Anne-Valérie Guizard; Brigitte Trétarre; Isabelle Stücker; Danièle Luce
Journal:  BMC Cancer       Date:  2013-11-28       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.